<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(8)</volume><submitter>Revol B</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>The DRAMES (Décès en Relation avec l'Abus de Médicaments Et de Substances) register is a database of drug-related deaths with the aim of identifying the psychoactive substances associated with and estimating the trends in these deaths. Our novel approach is based on the collection of data on all deaths for which toxicology experts have performed analyses.&lt;h4>Objective&lt;/h4>To describe drug-related deaths in France and report trends over an 11-year period.&lt;h4>Design, setting, and participants&lt;/h4>This case series used a national register to assess 4460 drug-related deaths that occurred from 2011 to 2021 in France. Data analyses were performed from January 1, 2012, to December 31, 2022.&lt;h4>Main outcomes and measures&lt;/h4>Demographic characteristics; medical and substance abu</pubmed_abstract><journal>JAMA network open</journal><pagination>e2331398</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10469283</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.</pubmed_title><pmcid>PMC10469283</pmcid><pubmed_authors>Kintz P</pubmed_authors><pubmed_authors>Spadari M</pubmed_authors><pubmed_authors>Lamiable D</pubmed_authors><pubmed_authors>Revol B</pubmed_authors><pubmed_authors>Mathieu O</pubmed_authors><pubmed_authors>Venisse N</pubmed_authors><pubmed_authors>Bouquet E</pubmed_authors><pubmed_authors>Delage M</pubmed_authors><pubmed_authors>Lavit M</pubmed_authors><pubmed_authors>Kergueris MF</pubmed_authors><pubmed_authors>Delavenne X</pubmed_authors><pubmed_authors>Gaillard Y</pubmed_authors><pubmed_authors>Morel I</pubmed_authors><pubmed_authors>Pepin G</pubmed_authors><pubmed_authors>Barret A</pubmed_authors><pubmed_authors>Citterio-Quentin A</pubmed_authors><pubmed_authors>Aquizerate A</pubmed_authors><pubmed_authors>Fouley A</pubmed_authors><pubmed_authors>Visinoni P</pubmed_authors><pubmed_authors>Lopez V</pubmed_authors><pubmed_authors>Eiden C</pubmed_authors><pubmed_authors>Sibille P</pubmed_authors><pubmed_authors>Goulle JP</pubmed_authors><pubmed_authors>Ganiere C</pubmed_authors><pubmed_authors>Devos B</pubmed_authors><pubmed_authors>Hoizey G</pubmed_authors><pubmed_authors>Gambier N</pubmed_authors><pubmed_authors>Lelievre B</pubmed_authors><pubmed_authors>Chaouachi L</pubmed_authors><pubmed_authors>Titier K</pubmed_authors><pubmed_authors>Gaulier JM</pubmed_authors><pubmed_authors>Lefeuvre S</pubmed_authors><pubmed_authors>Compagnie Nationale des Biologistes et Analystes Experts (CNBAE) and the French Addictovigilance Network (FAN)</pubmed_authors><pubmed_authors>Mura P</pubmed_authors><pubmed_authors>Billet-Chatenay C</pubmed_authors><pubmed_authors>Fouilhe Sam-Lai N</pubmed_authors><pubmed_authors>Deffontaine G</pubmed_authors><pubmed_authors>Lelong-Boulouard V</pubmed_authors><pubmed_authors>Bourgine J</pubmed_authors><pubmed_authors>Daveluy A</pubmed_authors><pubmed_authors>Le Meur C</pubmed_authors><pubmed_authors>Pelissier-Alicot AL</pubmed_authors><pubmed_authors>Labat-Deveaux L</pubmed_authors><pubmed_authors>Klinzig F</pubmed_authors><pubmed_authors>Bertin C</pubmed_authors><pubmed_authors>Mathieu-Daude JC</pubmed_authors><pubmed_authors>Perrin M</pubmed_authors><pubmed_authors>Roman E</pubmed_authors><pubmed_authors>Roussin A</pubmed_authors><pubmed_authors>Willeman T</pubmed_authors><pubmed_authors>Sabini S</pubmed_authors><pubmed_authors>Cheze M</pubmed_authors><pubmed_authors>Loilier M</pubmed_authors><pubmed_authors>Besnard T</pubmed_authors><pubmed_authors>Guerard P</pubmed_authors><pubmed_authors>Berland E</pubmed_authors><pubmed_authors>Lima-Tournebize J</pubmed_authors><pubmed_authors>Turcant A</pubmed_authors><pubmed_authors>Deslandes G</pubmed_authors><pubmed_authors>Roussel C</pubmed_authors><pubmed_authors>Dailly E</pubmed_authors><pubmed_authors>Mauras Y</pubmed_authors><pubmed_authors>Descoeur J</pubmed_authors><pubmed_authors>Lemaire-Hurtel AS</pubmed_authors><pubmed_authors>Ameline A</pubmed_authors><pubmed_authors>Peyre A</pubmed_authors><pubmed_authors>Rayer R</pubmed_authors><pubmed_authors>Vacher P</pubmed_authors><pubmed_authors>Saussereau E</pubmed_authors><pubmed_authors>Vieira O</pubmed_authors><pubmed_authors>Humbert L</pubmed_authors><pubmed_authors>Lacroix C</pubmed_authors><pubmed_authors>Martin-Molins C</pubmed_authors><pubmed_authors>Abbara C</pubmed_authors><pubmed_authors>Pok R</pubmed_authors><pubmed_authors>Allorge D</pubmed_authors><pubmed_authors>Milan N</pubmed_authors><pubmed_authors>Imbert L</pubmed_authors><pubmed_authors>Doche C</pubmed_authors><pubmed_authors>Chevallier C</pubmed_authors><pubmed_authors>Alvarez JC</pubmed_authors><pubmed_authors>Caous AS</pubmed_authors><pubmed_authors>Pineau A</pubmed_authors><pubmed_authors>Cesbron A</pubmed_authors><pubmed_authors>Moal A</pubmed_authors><pubmed_authors>Brunet B</pubmed_authors><pubmed_authors>Lacarelle B</pubmed_authors><pubmed_authors>Eysseric-Guerin H</pubmed_authors><pubmed_authors>Marty H</pubmed_authors><pubmed_authors>Descamps F</pubmed_authors><pubmed_authors>Deveaux M</pubmed_authors><pubmed_authors>Dumestre-Toulet V</pubmed_authors><pubmed_authors>Bevalot F</pubmed_authors><pubmed_authors>Scala-Bertola J</pubmed_authors><pubmed_authors>Ragoucy-Sengler C</pubmed_authors><pubmed_authors>Le Boisselier R</pubmed_authors><pubmed_authors>Manceau M</pubmed_authors><pubmed_authors>Collon-Fabie P</pubmed_authors><pubmed_authors>Le Bouil A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.</name><description>&lt;h4>Importance&lt;/h4>The DRAMES (Décès en Relation avec l'Abus de Médicaments Et de Substances) register is a database of drug-related deaths with the aim of identifying the psychoactive substances associated with and estimating the trends in these deaths. Our novel approach is based on the collection of data on all deaths for which toxicology experts have performed analyses.&lt;h4>Objective&lt;/h4>To describe drug-related deaths in France and report trends over an 11-year period.&lt;h4>Design, setting, and participants&lt;/h4>This case series used a national register to assess 4460 drug-related deaths that occurred from 2011 to 2021 in France. Data analyses were performed from January 1, 2012, to December 31, 2022.&lt;h4>Main outcomes and measures&lt;/h4>Demographic characteristics; medical and substance abu</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-04T22:55:26.4Z</modification><creation>2024-12-03T17:55:05.056Z</creation></dates><accession>S-EPMC10469283</accession><cross_references><pubmed>37647066</pubmed><doi>10.1001/jamanetworkopen.2023.31398</doi></cross_references></HashMap>